Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 457,977 |
|
|||||
| News | - | ||||||
| Day High | 15.03 | Low High |
|||||
| Day Low | 14.38 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Stoke Therapeutics Inc | STOK | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.30 | -2.04% | 14.41 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 14.81 | 14.38 | 15.03 | 14.41 | 14.71 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8,229 | 457,977 | $ 14.73 | $ 6,746,465 | - | 3.35 - 16.664 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:18:49 | 1 | $ 14.85 | USD |
Stoke Therapeutics (STOK) Options Flow Summary
Stoke Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 642.57M | 44.65M | - | 8.78M | -104.7M | -2.34 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Stoke Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical STOK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 14.11 | 16.664 | 13.73 | 15.44 | 778,555 | 0.30 | 2.13% |
| 1 Month | 11.69 | 16.664 | 10.97 | 13.07 | 764,470 | 2.72 | 23.27% |
| 3 Months | 7.74 | 16.664 | 5.60 | 11.95 | 1,449,418 | 6.67 | 86.18% |
| 6 Months | 3.91 | 16.664 | 3.77 | 10.96 | 803,846 | 10.50 | 268.54% |
| 1 Year | 11.79 | 16.664 | 3.35 | 9.86 | 560,801 | 2.62 | 22.22% |
| 3 Years | 37.28 | 41.60 | 3.35 | 12.99 | 356,203 | -22.87 | -61.35% |
| 5 Years | 27.21 | 71.58 | 3.35 | 17.52 | 281,068 | -12.80 | -47.04% |
Stoke Therapeutics Description
| Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. |
